These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 11342625)
21. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance. Deng C; Goluszko E; Christadoss P J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304 [TBL] [Abstract][Full Text] [Related]
22. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644 [TBL] [Abstract][Full Text] [Related]
23. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system. Evans R; Duffy TM; Kamdar SJ Eur J Immunol; 1991 Aug; 21(8):1815-9. PubMed ID: 1907916 [TBL] [Abstract][Full Text] [Related]
24. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs. Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885 [TBL] [Abstract][Full Text] [Related]
25. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells. Kishimoto H; Sprent J J Immunol; 1999 Aug; 163(4):1817-26. PubMed ID: 10438914 [TBL] [Abstract][Full Text] [Related]
26. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes. Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989 [TBL] [Abstract][Full Text] [Related]
27. Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis. Wigginton JM; Park JW; Gruys ME; Young HA; Jorcyk CL; Back TC; Brunda MJ; Strieter RM; Ward J; Green JE; Wiltrout RH J Immunol; 2001 Jan; 166(2):1156-68. PubMed ID: 11145697 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2. Yu XZ; Anasetti C Transplantation; 2000 Jan; 69(1):104-12. PubMed ID: 10653388 [TBL] [Abstract][Full Text] [Related]
29. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. Wei Y; Chen K; Sharp GC; Yagita H; Braley-Mullen H J Immunol; 2001 Dec; 167(11):6678-86. PubMed ID: 11714840 [TBL] [Abstract][Full Text] [Related]
30. Defective adhesion in tumor infiltrating CD8+ T cells. Koneru M; Monu N; Schaer D; Barletta J; Frey AB J Immunol; 2006 May; 176(10):6103-11. PubMed ID: 16670319 [TBL] [Abstract][Full Text] [Related]
31. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma. Koyama S; Koike N; Adachi S J Cancer Res Clin Oncol; 2001 Jan; 127(1):20-6. PubMed ID: 11206267 [TBL] [Abstract][Full Text] [Related]
32. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals. Telford WG; Nam SY; Podack ER; Miller RA Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701 [TBL] [Abstract][Full Text] [Related]
33. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity. Frost P; Ng CP; Belldegrun A; Bonavida B Cell Immunol; 1997 Aug; 180(1):70-83. PubMed ID: 9316641 [TBL] [Abstract][Full Text] [Related]
34. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Yoshida M; Takeuchi M; Streilein JW Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Uzzo RG; Rayman P; Kolenko V; Clark PE; Bloom T; Ward AM; Molto L; Tannenbaum C; Worford LJ; Bukowski R; Tubbs R; Hsi ED; Bander NH; Novick AC; Finke JH Clin Cancer Res; 1999 May; 5(5):1219-29. PubMed ID: 10353760 [TBL] [Abstract][Full Text] [Related]
36. Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells. Monu N; Frey AB Cancer Res; 2007 Dec; 67(23):11447-54. PubMed ID: 18056473 [TBL] [Abstract][Full Text] [Related]
37. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death. Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579 [TBL] [Abstract][Full Text] [Related]
38. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. Kemp RA; Ronchese F J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817 [TBL] [Abstract][Full Text] [Related]